MoneyWorks4Me

Bafna Pharmaceuticals’ unit gets renewal approval from MHRA

28 May 2018 Evaluate

Bafna Pharmaceuticals’ facility has received renewal approval as per the Guidelines of European Good Manufacturing Practices (EUGMP) from Medicines and Healthcare products Regulatory Agency (MHRA).

Bafna Pharmaceuticals is engaged in the production of tablets, capsule and oral syrup.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..